Study of Everolimus (RAD001) in Combination With Lenalidomide

Update Il y a 4 ans
Reference: NCT01218555

Woman and Man

Extract

The purpose of this study is to study the combination of two anticancer drugs, everolimus (RAD001) and lenalidomide in patients whose cancer is no longer responding to standard treatment or patients who are unable to tolerate the standard treatment for their cancer.


Inclusion criteria

  • Solid Organ Malignancies ,Adenoidcystic Carcinoma ,Neuroendocrine Tumors

Links